Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

Document Details

Document Type
Pub Defense Publication
Publication Date
Mar 01, 2021
Source ID
10.1016/j.ccell.2020.12.014

Entities

People

  • Barzin Y. Nabet
  • Bingnan Zhang
  • Bonnie S. Glisson
  • C Allison Stewart
  • Carl M. Gay
  • Carminia M. Della Corte
  • David S. Shames
  • Elizabeth M. Park
  • Giulia Fabbri
  • Ignacio I. Wistuba
  • Jack A. Roth
  • Jing Wang
  • John Minna
  • John V. Heymach
  • Junya Fujimoto
  • Kasey R Cargill
  • Kavya Ramkumar
  • Lauren Averett Byers
  • Lixia Diao
  • Luisa M Solis
  • Natalie I. Vokes
  • Paul Robson
  • Qi Wang
  • Robert J. Cardnell
  • Sarah M. Groves
  • Simon Heeke
  • Stephen G. Swisher
  • Vito Quaranta
  • Wei Lu
  • Yuanxin Xi

Organizations

  • Cancer Prevention and Research Institute of Texas
  • National Cancer Institute
  • United States Department of Defense